REFERENCES
- Hall AH, Kulig KW, Rumack BH. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. Journal de Toxicologie Clinique et Expérimentale 1989; 9: 3–9
- Fortin J-L, Ruttimann M, Domanski L, Kowalski JJ. Hydroxocobalamin: treatment for smoke inhalation-associated cyanide poisoning. Meeting the needs of fire victims. JEMS 2004; 29(suppl)18–21, [INFOTRIEVE], [CSA]
- Riou B, Gerard JL, La Rochelle CD, Bourdon R, Berdeaux A, Giudicelli JF. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anesthesiology 1991; 74: 552–558, [INFOTRIEVE], [CSA]
- Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19: 26–32, [INFOTRIEVE], [CSA], [CROSSREF]
- Borron SW, Barriot P, Imbert M, Baud FJ. Hydroxocobalamin for empiric treatment of smoke inhalation–associated cyanide poisoning: results of a prospective study in the prehospital setting. Ann Emer Med 2005; 46: S77, Abstract.[CSA], [CROSSREF]
- Fortin J-L, Ruttimann M, Domanski L, Kowalski JJ. Hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Prehosp Emerg Care 2006; 10: 142, Abstract.[CSA]
- Borron S, Mégarbane B, Baud FJ. Hydroxocobalamin is an effective antidote in severe acute cyanide poisoning in man. Int J Toxicol 2004; 23: 399–400, Abstract.[CSA]
- Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31: 277–294, [INFOTRIEVE], [CSA]
- Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol, 44(S1)17–29, [CSA]
- Jiang F, Li CG, Rand MJ. Effect of hydroxocobalamin on vasodilatations to nitrergic transmitter, nitric oxide and endothelium-derived relaxing factor in guinea-pig basilar artery. Eur J Pharmacol 1997; 340: 181–186, [INFOTRIEVE], [CSA], [CROSSREF]
- Colpaert EE, Lefebvre RA. Influence of bilirubin and other antioxidants on nitrergic relaxation in the pig gastric fundus. Br J Pharmacol 2000; 129: 1201–1211, [INFOTRIEVE], [CSA], [CROSSREF]
- Rajanayagam MA, Li CG, Rand MJ. Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 1993; 108: 3–5, [INFOTRIEVE], [CSA]
- Correia NA, Cavalcanti PM, Oliveira RB, Ballejo G. Effect of hydroquinone, hydroxocobalamin and carboxy-PTIO on nonadrenergic noncholinergic nerve mediated relaxations of the rat duodenum. J Auton Pharmacol 1999; 19: 233–240, [INFOTRIEVE], [CSA], [CROSSREF]
- Li CG, Rand MJ. Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles. Br J Pharmacol 1999; 127: 172–176, [INFOTRIEVE], [CSA], [CROSSREF]
- Greenberg SS, Xie J, Zatarain JM, Kapusta DR, Miller MJ. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 1995; 273: 257–265, [INFOTRIEVE], [CSA]
- Kruszyna H, Magyar JS, Rochelle LG, Russell MA, Smith RP, Wilcox DE. Spectroscopic studies of nitric oxide interactions with cobalamins: reaction of NO with superoxocobalamin(III) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 1998; 285: 665–671, [INFOTRIEVE], [CSA]
- Rochelle LG, Morana SJ, Kruszyna H, Russell MA, Wilcox DE, Smith RP. Interactions between hydroxocobalamin and nitric oxide: evidence for a redox reactions between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995; 275: 48–52, [INFOTRIEVE], [CSA]
- Sharma VS, Pilz RB, Boss GR, Magde D. Reactions of nitric oxide with vitamin B12 and its precursor, cobinamide. Biochemistry 2003; 42: 8900–8908, [INFOTRIEVE], [CSA], [CROSSREF]
- Losonczy G, Mucha I, Müller V, Kriston T, Ungvári Z, Tornóci L, Rosivall L, Venuto R. The vasoconstrictor effects of L-NAME, a nitric oxide synthase inhibitor, in pregnant rabbits. Brit J Pharmacol 1996; 118: 1012–1018, [CSA]
- Mastronicola D, Arcuri E, Arese M, Bacchi A, Mercadente S, Cardelli P, et al. Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells. Cell Mol Life Sci 2004; 61: 2991–2997, [INFOTRIEVE], [CSA], [CROSSREF]